Majic Wheels Corp. (OTCMKTS: MJWL) (“Majic Wheels Corp.” or the “Company”) announced today that the Company has been acquired by an investment firm. The company will assist in developing antivirals drugs and vaccines from key developers. The company will also support vaccine and antivirals clinical trials. The company will maintain the highest-level of safety when it comes to testing, manufacturing and transferring of products.
Environ PharmaVaccine Inc or Majic Wheels Corp understands the technology and medicine in the antivirals and vaccine industry which is consistently progressing. Our team of experienced professionals stay current about the latest drug trends, diseases, and viruses.
The coronavirus that originated from Wuhan China is spreading fast. The coronavirus belongs to the coronavirus family, a category that includes Severe Acute Respiratory Syndrome (SARS) and Middle East Respiratory Syndrome (MERS) and that typically results in respiratory illnesses. Our team of professionals are currently monitoring and working with antiviral and vaccine developers to control the spread of the coronavirus.
The company is going to update its shareholders and the public through proper newswires in the coming days.
Environ PharmaVaccine Inc or Majic Wheels Corp. Forward-Looking Statements
This press release contains statements that the Company believes to be “forward-looking statements” within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. All statements other than historical facts, including, without limitation, statements regarding the investment offerings and the terms thereof, are forward-looking statements. When used in this press release, words such as we “expect”, “intend”, “plan”, “estimate”, “anticipate”, “believe”, “should”, or the negative thereof or similar terminology are generally intended to identify forward-looking statements. Such forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from those expressed in, or implied by, such statements. Investors should not place undue reliance upon forward-looking statements. The Company disclaims any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.